3J 4.9, b-H), 9.02 (2 H, d, 3J 4.9, b-H), 8.10 (4 H, d, 4J 1.7, o-Ar–H),
7.85 (2 H, t, 4J 1.7, p-Ar–H), 6.84 (1 H, d, 3J 15.9, alkene-H), 4.07
(3 H, s, CH3), 1.57 (overlapping H2O, s, tBu–H), −2.80 (2 H, br s,
N–H). H218: found: C, 78.8; H, 7.3; N, 6.5. Calc. for C56H63N4O4:
C, 78.6; H, 7.4; N, 6.5; HRMS (ESI+) m/z = 855.4837.
Calc. MH+ for C56H63N4O4 m/z = 855.4849; dH 10.24 (2 H,
collected. This fraction corresponded to H215, which resulted
from debromination of the intermediate bromo(alkenyl)porphyrin
(1.6 mg, 7.5%). Once H215 was isolated, the eluent was changed
to CH2Cl2–n-hexane (70 : 30) and a second fraction (H219)
was collected and recrystallised from CH2Cl2–MeOH as a dark
powder (17.8 mg, 69%). H215: dH 10.15 (1 H, s, meso-H), 9.76
(1 H, d, 3J 15.9, alkene-H), 9.60 (2 H, d, 3J 4.6, b-H), 9.31
3
3
3
d, J 15.7, alkene-H), 9.44 (4 H, d, J 4.9, b-H), 8.92 (4 H, d, J
4.9, b-H), 8.06 (4 H, d, 4J 1.7, o-Ar–H), 7.85 (2 H, t, p-Ar–H), 6.84
(1 H, d, 3J 15.9, alkene-H), 4.06 (6 H, s, CH3), 1.56 (overlapping
3
3
(2 H, d, J 4.6, b-H), 9.06 (2 H, d, J 4.6, b-H), 9.04 (2 H, d,
3J 4.6, b-H), 8.16 (4 H, d, J 1.5, o-Ar–H), 7.98 (2 H, d, J 7.3,
o-phenylethenyl-H), 7.87 (2 H, t, 4J 1.5, p-Ar–H), 7.60 (2 H, t, 3J
7.3, m-phenylethenyl-H), 7.48 (1 H, t, 3J 7.3, p-phenylethenyl-H),
7.44 (1 H, d, 3J 15.9, alkene-H), 1.56 (overlapping H2O, s, tBu–H),
−2.69 (2 H, br s, N–H). H219: found: C, 86.2; H, 7.55; N, 6.3.
Calc. for C64H66N4: C, 86.25; H, 7.5; N, 6.3%. dH 9.63 (2 H, d,
4
3
t
H2O, s, Bu–H); UV–vis: kmax (log e) 433 (5.24), 533 (3.79), 580
(4.03), 674 (3.75) nm.
E-5-(2-Methoxycarbonylethenyl)-10,20-bis(3,5-di-tert-butyl-
phenyl)porphyrinatonickel(II) (Ni14) and E,E-5,15-bis(2-methoxy-
carbonylethenyl)-10,20-bis(3,5-di-tert-butylphenyl)porphyrinato-
nickel(II) (Ni18). Produced from the reaction between Ni6
(26.1 mg) and methyl acrylate (260 lL). CHCl3–n-hexane
(50 : 50) was used as the initial eluent and the first fraction
was collected. This fraction corresponded to Ni14 (1.2 mg,
5%), which resulted from debromination of the intermediate
bromo(alkenyl)porphyrin. Once the first fraction was isolated, the
eluent was changed to CHCl3–n-hexane (80 : 20) and a second
fraction (Ni18) was collected and recrystallised from CHCl3–
MeOH to give a dark powder (18.5 mg, 70%). Ni14: dH 9.77 (1 H,
d, 3J 15.6, alkene-H), 9.71 (1 H, s, meso-H), 9.40 (2 H, d, 3J 4.8,
b-H), 9.07 (2 H, d, 3J 4.8, b-H), 8.91 (2 H, d, 3J 4.8, b-H), 8.84 (2 H,
d, 3J 4.8, b-H), 7.85 (4 H, d, 4J 1.8, o-Ar–H), 7.75 (2 H, t, 4J 1.8,
p-Ar–H), 6.36 (1 H, d, 3J 15.6, alkene-H), 3.97 (3 H, s, CH3), 1.50
3
3
3J 15.9, alkene-H), 9.46 (4 H, d, J 4.6, b-H), 8.89 (4 H, d, J
4
3
4.6, b-H), 8.09 (4 H, d, J 1.5, o-Ar–H), 7.96 (4 H, d, J 7.6,
3
o-phenylethenyl-H), 7.83 (2 H, t, p-Ar–H), 7.58 (4 H, d, J 7.6,
m-phenylethenyl-H), 7.46 (2 H, d, 3J 7.6, p-phenylethenyl-H),
7.46 (1 H, d, 3J 15.9, alkene-H), 1.56 (overlapping H2O, s, tBu–H),
−2.20 (2 H, s, N–H); UV–vis: kmax (log e) 437 (5.31), 535 (3.79),
584 (4.16), 677 (3.83) nm.
E-5-(2-Phenylethenyl)-10,20-bis(3,5-di-tert-butylphenyl)porphy-
rinatonickel(II) (Ni15) and E,E-5,15-bis(2-phenylethenyl)-10,20-
bis(3,5-di-tert-butylphenyl)porphyrinatonickel(II)
(Ni19). Pro-
duced from the reaction between Ni6 (26.1 mg) and styrene (275
lL). CHCl3–n-hexane (20 : 80) was used as the initial eluent and
the first fraction was collected. This fraction corresponded to
Ni15, which resulted from debromination of the intermediate
bromo(alkenyl)porphyrin (1.2 mg, 5%). Once the first fraction
was isolated, the eluent was changed to neat CHCl3 and a second
fraction was collected (Ni19), which was recrystallised from
CHCl3–MeOH as a dark powder (19.2 mg, 70%). Ni15: dH 9.77
t
(36 H, s, Bu–H), −2.80 (2 H, br s, N–H). Ni18: HRMS (ESI+)
m/z = 910.4014. Calc. M+ for C56H60N4O4Ni m/z = 910.3968;
found: C, 73.75; H, 6.8; N, 6.2. Calc. for C56H60N4O4Ni: C, 73.8;
H, 6.6; N, 6.1%; dH 9.81 (2 H, d, 3J 15.6, alkene-H), 9.30 (4 H, d, 3J
4.9, b-H), 8.78 (4 H, d, 3J 4.9, b-H), 7.79 (4 H, d, 4J 1.8, o-Ar–H),
7.74 (2 H, t, 4J 1.8, p-Ar–H), 6.30 (1 H, d, 3J 15.6, alkene-H), 3.95
(6 H, s, CH3), 1.49 (36 H, s, tBu–H); UV–vis: kmax (log e) 441 (5.18),
569 (3.97), 616 (4.20) nm.
3
(1 H, d, J 16.1, alkene-H), 9.64 (1 H, s, meso-H), 9.44 (2 H,
3
3
3
d, J 4.9, b-H), 9.38 (2 H, d, J 4.7, b-H), 9.07 (2 H, d, J 4.9,
3
4
b-H), 8.90 (2 H, d, J 4.7, b-H), 7.89 (4 H, d, J 1.8, o-Ar–H),
7.82 (2 H, d, J 7.6, o-phenylethenyl-H), 7.76 (2 H, t, J 1.8,
p-Ar–H), 7.52 (2 H, t, J 7.6, m-phenylethenyl-H), 7.40 (1 H, J
7.6, p-phenylethenyl-H), 6.94 (1 H, d, J 16.1, alkene-H), 1.50
3
4
3
3
E,E-5,15-Bis(2-methoxycarbonylethenyl)-10,20-bis(3,5-di-tert-
butylphenyl)porphyrinatozinc(II) (Zn18). Produced as the main
product from the reaction between Zn6 (26.3 mg) and methyl
acrylate (230 lL). The product was purified by column chromatog-
raphy using CHCl3–n-hexane (50 : 50) as the eluent. After the first
band, which consisted of a number of unidentified porphyrins
(5.1 mg), eluted from the column, the solvent was changed to
CHCl3–MeOH (99 : 1), and the second fraction (Zn18) was
collected and recrystallised from CHCl3(1% pyridine)–MeOH as a
dark green powder (18.4 mg, 69%). HRMS (ESI+) m/z = 916.3996.
Calc. MH+ for C56H60N4O4Zn m/z = 916.3906; found: C, 73.3; H,
6.6; N, 6.1. Calc. for C56H60N4O4Zn: C, 73.2; H, 6.6; N, 6.1%; dH
10.22 (2 H, d, 3J 15.8, alkene-H), 9.53 (4 H, d, 3J 4.8, b-H), 9.04
3
t
(overlapping H2O, s, Bu–H). Ni19: found: C, 81.3; H, 6.9; N,
5.9. Calc. for C64H64N4Ni: C, 81.1; H, 6.8; N, 5.9%. dH 9.30 (4 H,
3
3
d, J 4.9, b-H), 9.23 (2 H, d, J 16.1, alkene-H), 8.74 (4 H, d,
3J 4.9, b-H), 7.82 (4 H, d, J 1.8, o-Ar–H), 7.78 (4 H, d, J 7.6,
o-phenylethenyl-H), 7.71 (2 H, t, 4J 1.8, p-Ar–H), 7.49 (2 H, t, 3J
7.6, m-phenylethenyl-H), 7.37 (2 H, t, 3J 7.6, p-phenylethenyl-H),
6.84 (1 H, d, J 16.1, alkene-H), 1.48 (36 H, s, Bu–H); UV–vis:
kmax (log e) 447 (5.22), 569 (4.04), 616 (4.23) nm.
4
3
3
t
E,E-5,15-Bis(2-phenylethenyl)-10,20-(3,5-di-tert-butylphenyl)
porphyrinatozinc(II) (Zn19). Produced as the main product from
the reaction between Zn6 (26.3 mg) and styrene (275 lL). The
product was purified by column chromatography using CHCl3–n-
hexane (40 : 60) as the eluent. After the first band, which consisted
of a number of unidentified porphyrins (7.5 mg), eluted from
the column, the solvent was changed to pure CHCl3, and the
second fraction was collected and recrystallised from CHCl3(1%
pyridine)–MeOH to yield Zn19 as a dark powder (16.6 mg, 60%).
Found: C, 80.5; H, 6.8; N, 5.9. Calc. for C64H64N4Zn: C, 80.5; H,
6.8; N, 5.9%; dH 9.69 (2 H, d, 3J 15.8, alkene-H), 9.60 (4 H, d, 3J
4.8, b-H), 9.02 (4 H, d, 3J 4.8, b-H), 8.10 (4 H, d, 4J 1.8, o-Ar–H),
3
4
(4 H, d, J 4.8, b-H), 8.08 (4 H, d, J 1.8, o-Ar–H), 7.95 (2 H, t,
p-Ar–H), 6.73 (1 H, d, 3J 15.8, alkene-H), 3.97 (6 H, s, CH3), 1.57
(36 H, s, Bu–H); UV–vis: kmax (log e) 439 (5.28), 571 (2.76), 629
t
(4.04).
E-5-(2-Phenylethenyl)-10,20-bis(3,5-di-tert-butylphenyl)porphy-
rin (H215) and E,E-5,15-bis(2-phenylethenyl)-10,20-bis(3,5-di-tert-
butylphenyl)porphyrin (H219). Produced from the reaction
between H26 (24.5 mg) and styrene (275 lL). CH2Cl2–n-hexane
(30 : 70) was used as the initial eluent and the first fraction was
This journal is
The Royal Society of Chemistry 2006
Org. Biomol. Chem., 2006, 4, 902–916 | 913
©